BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4334084)

  • 1. Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors.
    Foley JF; Lemon HM; Miller D
    Cancer Chemother Rep; 1970 Feb; 54(1):41-6. PubMed ID: 4334084
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
    Stephens RL; Hoogstraten B
    Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053).
    Senyszyn JJ; Johnson RE; Curran RE
    Cancer Chemother Rep; 1970 Apr; 54(2):103-7. PubMed ID: 4945999
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of common solid tumours in a general surgical unit.
    Jones KD; Hughes LE
    Clin Oncol; 1979 Mar; 5(1):51-63. PubMed ID: 421387
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with cyclophosphamide (NSC-26271), cytosine arabinoside (NSC-63878), and methotrexate (NSC-740) in advanced solid tumors.
    Odujinrin OO; DeConti RC; Bertino JR
    Cancer Chemother Rep; 1975; 59(6):1091-6. PubMed ID: 769948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
    Gary-Bobo J
    J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
    Umsawasdi T; Nilprabhassorn P
    J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
    Taylor SG; Desai SA; DeWys WD
    Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
    Slack NM; Jones R
    Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
    Hill GJ; Larsen RR
    Oncology; 1972; 26(2):206-22. PubMed ID: 4626137
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of residual disease in solid tumours.
    Kenis Y
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):103-7. PubMed ID: 4324078
    [No Abstract]   [Full Text] [Related]  

  • 13. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
    Cohen SM; Weiner MJ; Greenspan EM
    Cancer Chemother Rep; 1972 Dec; 56(6):751-4. PubMed ID: 4660631
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of antimetabolites in the treatment of breast and colon cancer.
    JAMA; 1967 May; 200(9):770-8. PubMed ID: 5337107
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in prevention of the recurrence of resectable cancer.
    Bonadonna G; Tancini G; Rossi A; Gasparini M
    Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C; Ngo Minh Man
    Presse Med (1893); 1969 Mar; 77(11):385-8. PubMed ID: 4891646
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.